Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
Meng Zhang(Shenzhen University), Chawnshang Chang(University of Rochester Medical Center)
Cited by 17
Related Papers
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
|Nature Communications|2019|223
Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen Receptor
|The Journal of Experimental Medicine|2003|148
Post-transcriptional regulation of mouse neurogenesis by Pumilio proteins
|Genes & Development|2017|130
Metformin Inhibits Nuclear Receptor TR4–Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity
|Diabetes|2011|97
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
|Nature Communications|2020|92